Dow Bribe-Related Suit Tossed
Chairman Andrew Liveris and 11 other members of Dow Chemical’s board were named in the shareholder derivative suit. A Delaware chancery court this week cited Dow Chemical’s corporate compliance program as a reason for dismissing a shareholder derivative suit against the company’s current directors that alleged they failed to prevent overseas bribery.… Continue Reading